Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-03-30

FDA Approved: JADENU — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved JADENU (deferasirox) through an Original Application for the treatment of chronic iron overload due to blood transfusions; the tablet formulation p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JADENU (deferasirox)

Snippet

ORIG AP for JADENU (DEFERASIROX)